| Current status of alcohol septal ablation for patients with hypertrophic cardiomyopathy. | |
| | |
MedLine Citation:
|
PMID: 11177675 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Since the early 1960s, surgical myotomy-myectomy has been the standard treatment for patients with drug-refractory symptoms due to hypertrophic cardiomyopathy and dynamic outflow tract obstruction. Comparable morphologic and functional results can be achieved by percutaneous septal ablation (PTSMA) by alcohol-induced septal branch occlusion. The circumscribed therapeutic myocardial infarction results in widening of the left ventricular outflow tract with consecutive gradient reduction. Follow-up studies show clinical and objective improvement as well as further gradient reduction due to left ventricular remodeling. In this article, an updated review of the latest results of PTSMA is provided. |
| | |
Authors:
|
H Seggewiss |
Related Documents
:
|
7890275 - The pattern of desmin filaments in myocardial disarray. 20102955 - Usefulness of delayed enhancement by magnetic resonance imaging in hypertrophic cardiom... 7605645 - The left ventricular resectoscope. a new instrument for the comprehensive resection of ... 19544675 - Takotsubo cardiomyopathy: case report and review of the literature. 11348055 - Successfully treated unstable angina pectoris in a young japanese female. 18695435 - Transient trifascicular block complicating myocardial contusion after blunt chest traum... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current cardiology reports Volume: 3 ISSN: 1523-3782 ISO Abbreviation: Curr Cardiol Rep Publication Date: 2001 Mar |
Date Detail:
|
Created Date: 2001-02-22 Completed Date: 2001-06-14 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 100888969 Medline TA: Curr Cardiol Rep Country: United States |
Other Details:
|
Languages: eng Pagination: 160-6 Citation Subset: IM |
Affiliation:
|
Medizinische Klinik I, Leopoldina-Krankenhaus, Gustav-Adolf-Strasse 8, 97422, Schweinfurt, Germany. hseggewiss@leopoldina.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cardiomyopathy, Hypertrophic
/
therapy* Ethanol / administration & dosage* Follow-Up Studies Humans |
| Chemical | |
Reg. No./Substance:
|
64-17-5/Ethanol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The role of exercise testing in the evaluation of the patient with hypertrophic cardiomyopathy.
Next Document: The role of pharmacologic treatment to prevent sudden death in the implantable cardioverter defibril...